Tirzepatide (Zepbound) is a dual incretin therapy that targets GLP-1 and GIP receptors to promote significant weight loss. Clinical trials show up to 22.5% body weight reduction with minimal hunger, but side effects like nausea are common. Learn how it works, who it's for, and what to expect.
read more